期刊文献+

不同手术方式治疗老年非小细胞肺癌患者的疗效及预后 被引量:20

下载PDF
导出
摘要 目的探讨两种不同微创手术方式治疗老年非小细胞肺癌(NSCLC)患者疗效与预后。方法老年NSCLC患者84例,按照患者意愿依据手术方式不同分为对照组(44例)和观察组(40例),对照组施行小切口开胸术,观察组施行全胸腔镜下肺叶切除术,对比两组治疗效果及预后状况。结果两组手术时间、术中出血量无明显差异(P>0.05);观察组术后引流量、术后引流时间、住院时间明显低于对照组(P<0.05);两组淋巴结清扫数目、总体并发症发生率无明显差异(P>0.05);观察组术后疼痛评分明显低于对照组(P<0.05);术后1年,观察组发生转移率、生存率与对照组无明显差异(P>0.05)。结论全胸胸腔镜下肺叶切除术治疗老年NSCLC患者与小切口开胸术患者相比安全性、有效性及预后无明显差异,但其具有术后恢复快、疼痛程度低等优势。
出处 《中国老年学杂志》 CAS 北大核心 2020年第11期2302-2304,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献11

二级参考文献116

  • 1郝捷,陈万青(主编).中国肿瘤登记年报(2012)[M].北京:军事医学科学出版社,2012.12-30.
  • 2Li B, Liu J, Feng R, et al. The tumor-immune index is correlated with the prognosis of patients after curative resection for nonsmall cell lung cancer[J]. Medicine (Baltimore), 2015, 94 (48): e2174. DOI: 10. 1097/MD. 0000000000002174.
  • 3BluthgenMV, Besse I3. Second-line combination therapies in nonsmall cell lung cancer without known driver mutations[J]. Eur Respir Rev, 2015, 24 (138) : 582 593. DOI: 10. 1183/16000617. 00002115.
  • 4Remon J, Gorham J, Besse B, et al. Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients[J]. Eur Respir J, 2015,46 ( 6 ) : 1548 1550. DOI: 10. 1183/13993003. 01482-2015.
  • 5Jin J, Liu BZ, Wu ZM. Evaluation of melanoma antigen gene A3 expression in drug resistance of epidermal growth factor receptotyrosine kinase inhibitors in advanced nonsmall cell lung cancer treatment [J]. J Cancer Res Ther. 2015, 11 Suppl: C271-4. 1X)I.. 10. 4103/0973 1482. 170549.
  • 6Ju Y, Hu Y, Sun S, et al. Toxicity and adverse effects of everolimus in the treatment of advanced nonsmall cell lung cancer pretreated with chemotherapy Chinese experiences [J ] . Indian J Cancer,2015, 52 Suppl: E32 E36. PA)I: 10.4103/ 0019 509X. 168954.
  • 7Yin X, Ying J, 1.i L, et al. A metaanalysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer [J]. Indian J Cancer, 2015, 52 Suppl: E29-E31. DOI: 10. 4103/ 0019-509X. 168953.
  • 8Yoshino R, Imai H, Mori K, et al. Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer[J]. J Cancer Res Ther, 2015, 11 (3): 606-611. DOI: 10.4103/0973 1482. 163683.
  • 9Xie S, Zeng W, Fan G, et al. Effect of CXCLI2/CXCR4 on increasing the metastatic potential of non - small cell lung cancer in vitro is inhibited through the downregulation of CXCR4 chemokine receptor expression [J]. Oncol Lett, 2014, 7 (4): 941-947.
  • 10Phemambucq EC, Hartemink KJ, Smit EF, et al. Tumor cavitation in patients with stage 11I non - small'- cell lung cancer undergoing concurrent chemoradiotherapy: incidence and oulcomes [ J ]. ] ThoracOncol, 2012, 7 (8): 1271-1275.

共引文献285

同被引文献200

引证文献20

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部